Updated ARROW data: Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC)

Authors

Publication/Presentation Date

9-2022

Volume

33

Issue

7

First Page

1298

Last Page

1299

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article

Share

COinS